Showing results (1841-1850 of 3,600) with videos related to
Sort By:
Pageof 360
Human Immunology|July 22, 2026
IL10 promoter variants in neurocysticercosis: family-based susceptibility and exploratory genotype-phenotype analyses in Mexican case-parent triosM Villegas, A Fleury, C Alaez, et al.Current Oncology (Toronto, Ont.)|January 13, 2021
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in CanadaJean Lachaine, Catherine Beauchemin, Kimberly Guinan, et al.Protist|February 2, 2002
Basal body-associated nucleation center for the centrin-based cortical cytoskeletal network in ParameciumJ Beisson, J C Clérot, A Fleury-Aubusson, et al.NPJ Vaccines|February 7, 2020
Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo modelsMarco Tamborrini, Julia Hauser, Anja Schäfer, et al.Clinical Radiology|September 15, 2020
Solitary dilated duct visualised by mammography: ultrasound and anatomopathological correlationV J Ayres, L C Ramalho, C E Fernandes, et al.L'Encephale|September 2, 2022
[Minors in a French custody center: Sociodemographic characteristics, global health and vulnerability factors]C Poullaouec, N Vabres, C Ayou, et al.JBRA Assisted Reproduction|June 28, 2022
Music therapy in stress: proposal of extension to Assisted ReproductionEliamar Aparecida de B Fleury, Mario S Approbato, Tatiana M da Silva, et al.The Pediatric Infectious Disease Journal|August 13, 2003
Congenital toxoplasmosis in twins: a report of fourteen consecutive cases and a comparison with published dataFrancois Peyron, Athanase B Ateba, Martine Wallon, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2000
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisoloneF Keime-Guibert, F Graus, A Fleury, et al.HIV Clinical Trials|October 9, 2001
Progression to AIDS or death as endpoints in HIV clinical trialsF Raffi, G Chêne, R Lassalle, et al.Pageof 360